Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

Introducing continuous glucose monitoring in primary care optimizes diabetes management in underserved populations.

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...

(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today ...

Over-the-counter continuous glucose monitors have gained popularity over recent years. These devices are designed to help people manage diabetes and other conditions that require monitoring of their ...

BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation ...

A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.

Ultrahuman has launched M2 Live in the US, combining Abbott's Lingo glucose monitor with AI-powered metabolic insights at a lower entry price.The Latest Tech News, Delivered to Your Inbox ...

Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...

Keeping tabs on blood sugar throughout the day used to be the exclusive domain of people with diabetes. But in 2026, anyone ...

According to MarketsandMarkets™, the Patient Monitoring Devices Market is projected to grow from about USD 55.60 billion in 2026 to USD 76.11 billion by 2031, at a CAGR of 6.4%.